4.5 Review

Correlation of Platelet and Coagulation Function with Blood Stasis Syndrome in Coronary Heart Disease: A Systematic Review and Meta-Analysis

期刊

CHINESE JOURNAL OF INTEGRATIVE MEDICINE
卷 27, 期 11, 页码 858-866

出版社

SPRINGER
DOI: 10.1007/s11655-021-2871-2

关键词

coronary heart disease; blood stasis syndrome; platelet; coagulation

资金

  1. China Academy of Chinese Medical Sciences [ZZ13-036-4]
  2. Special Fund of Xiyuan Hospital of China Academy of Chinese Medical Sciences for the Cultivation of the National Natural Science Foundation of China [XY20-01]

向作者/读者索取更多资源

The study found that among CHD patients, those with BSS exhibited increased platelet function, hypercoagulability, and decreased fibrinolytic activity.
Objective To investigate the correlation of platelet and coagulation function with blood stasis syndrome (BSS) in coronary heart disease (CHD). Methods The protocol for this meta-analysis was registered on PROSPERO (CRD42019129452). PubMed, Excerpta Medica Database (Embase), the Cochrane Library, and China National Knowledge Infrastructure (CNKI) were searched from inception to 1st June, 2020. Trials were considered eligible if they enrolled BSS and non-BSS (NBSS) patients with CHD and provided information on platelet and coagulation function. The platelet function, coagulation function, and fibrinolytic activity were compared between the BSS and NBSS groups. Forest plots were generated to show the SMDs or ESs with corresponding 95% CIs for each study. Subgroup analysis and sensitivity analysis were performed to explore potential sources of heterogeneity. Results The systematic search identified 1,583 articles. Thirty trials involving 10,323 patients were included in the meta-analysis. The results showed that mean platelet volume, platelet distribution width, platelet aggregation rate, platelet P selectin, fibrinogen, plasminogen activator inhibitor-1 (PAI-1), thromboxane B2 (TXB2), 6-keto-prostaglandin F1alpha (6-keto-PGF1 alpha), and TXB2/6-keto-PGF1 alpha were higher in the BSS group than in the NBSS group (PP<0.01). Activated partial thromboplastin time was lower in the BSS group than in the NBSS group in the acute phase of CHD (P<0.01). The R and K values in thromboelastography and tissue plasminogen activator (t-PA) and t-PA/PAI-1 were lower in the BSS group than in the NBSS group (all P<0.01). No difference was found in the results of platelet count, plateletcrit, maximum amplitude, von Willebrand factor, prothrombin time, thrombin time, international normalized ratio, etc. between groups. Conclusions Increased platelet function, hypercoagulability, and decreased fibrinolytic activity were found among CHD patients with BSS.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据